These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Redefining the Epstein-Barr virus-encoded nuclear antigen EBNA-1 gene promoter and transcription initiation site in group I Burkitt lymphoma cell lines. Schaefer BC; Strominger JL; Speck SH Proc Natl Acad Sci U S A; 1995 Nov; 92(23):10565-9. PubMed ID: 7479841 [TBL] [Abstract][Full Text] [Related]
26. Epstein-Barr virus and the pathogenesis of Burkitt's lymphoma: more questions than answers. Bornkamm GW Int J Cancer; 2009 Apr; 124(8):1745-55. PubMed ID: 19165855 [TBL] [Abstract][Full Text] [Related]
27. Adult B-cell lymphomas with burkitt-like morphology are phenotypically and genotypically heterogeneous with aggressive clinical behavior. McClure RF; Remstein ED; Macon WR; Dewald GW; Habermann TM; Hoering A; Kurtin PJ Am J Surg Pathol; 2005 Dec; 29(12):1652-60. PubMed ID: 16327438 [TBL] [Abstract][Full Text] [Related]
28. Inactivation of the von Hippel-Lindau (VHL) tumour suppressor gene and allelic losses at chromosome arm 3p in primary renal cell carcinoma: evidence for a VHL-independent pathway in clear cell renal tumourigenesis. Clifford SC; Prowse AH; Affara NA; Buys CH; Maher ER Genes Chromosomes Cancer; 1998 Jul; 22(3):200-9. PubMed ID: 9624531 [TBL] [Abstract][Full Text] [Related]
29. Sequential karyotyping in Burkitt lymphoma reveals a linear clonal evolution with increase in karyotype complexity and a high frequency of recurrent secondary aberrations. Aukema SM; Theil L; Rohde M; Bauer B; Bradtke J; Burkhardt B; Bonn BR; Claviez A; Gattenlöhner S; Makarova O; Nagel I; Oschlies I; Pott C; Szczepanowski M; Traulsen A; Kluin PM; Klapper W; Siebert R; Murga Penas EM Br J Haematol; 2015 Sep; 170(6):814-25. PubMed ID: 26104998 [TBL] [Abstract][Full Text] [Related]
30. [Localization of 8q24 break-point of Burkitt lymphoma in Japan : relationship to EBV status]. Tatsumi E; Ohno H Nihon Rinsho; 1997 Feb; 55(2):429-35. PubMed ID: 9046836 [TBL] [Abstract][Full Text] [Related]
31. Genome-wide allelotyping of lung cancer identifies new regions of allelic loss, differences between small cell lung cancer and non-small cell lung cancer, and loci clustering. Girard L; Zöchbauer-Müller S; Virmani AK; Gazdar AF; Minna JD Cancer Res; 2000 Sep; 60(17):4894-906. PubMed ID: 10987304 [TBL] [Abstract][Full Text] [Related]
32. Transfection of the c-myc oncogene into normal Epstein-Barr virus-harboring B cells results in new phenotypic and functional features resembling those of Burkitt lymphoma cells and normal centroblasts. Cutrona G; Ulivi M; Fais F; Roncella S; Ferrarini M J Exp Med; 1995 Feb; 181(2):699-711. PubMed ID: 7836923 [TBL] [Abstract][Full Text] [Related]
33. Epstein-Barr virus integration in human lymphomas and lymphoid cell lines. Gulley ML; Raphael M; Lutz CT; Ross DW; Raab-Traub N Cancer; 1992 Jul; 70(1):185-91. PubMed ID: 1318776 [TBL] [Abstract][Full Text] [Related]
34. Burkitt lymphoma (BL): reclassification of 39 lymphomas diagnosed as BL or Burkitt-like lymphoma in the past based on immunohistochemistry and fluorescence in situ hybridization. Kodet R; Mrhalová M; Stejskalová E; Kabícková E Cesk Patol; 2011 Jul; 47(3):106-14. PubMed ID: 21887927 [TBL] [Abstract][Full Text] [Related]
35. Chromosome #14 markers in two Epstein-Barr virus (EBV)-transformed lymphoblastoid cell lines of normal origin differ from the Burkitt lymphoma (BL)-associated 14q+ marker. Manolov G; Manolova Y; Klein G; Levan A; Kieler J Cancer Genet Cytogenet; 1981 Oct; 4(2):179-84. PubMed ID: 6277469 [TBL] [Abstract][Full Text] [Related]
36. Histological characteristics of 21 Papua New Guinean children with high-grade B-cell lymphoma, which is frequently associated with EBV infection. Nomura Y; Lavu EK; Muta K; Niino D; Takeshita M; Hirose S; Nakamura S; Yoshino T; Kikuchi M; Ohshima K Pathol Int; 2008 Nov; 58(11):695-700. PubMed ID: 18844934 [TBL] [Abstract][Full Text] [Related]
37. Low incidence of MYC/BCL2 double-hit in Burkitt lymphoma. Yoshida M; Ichikawa A; Miyoshi H; Kiyasu J; Kimura Y; Niino D; Ohshima K Pathol Int; 2015 Sep; 65(9):486-9. PubMed ID: 26182827 [TBL] [Abstract][Full Text] [Related]
38. T cell leukemia I oncogene expression depends on the presence of Epstein-Barr virus in the virus-carrying Burkitt lymphoma lines. Kiss C; Nishikawa J; Takada K; Trivedi P; Klein G; Szekely L Proc Natl Acad Sci U S A; 2003 Apr; 100(8):4813-8. PubMed ID: 12672960 [TBL] [Abstract][Full Text] [Related]
39. Sensitivity to dexamethasone and absence of bcl-2 protein in Burkitt's lymphoma cell line (Black93) derived from a patient with acute tumor lysis syndrome: comparative study with other BL and non-BL lines. Tani A; Tatsumi E; Nakamura F; Kumagai S; Kosaka Y; Sano K; Nakamura H; Amakawa R; Ohno H Leukemia; 1996 Oct; 10(10):1592-603. PubMed ID: 8847894 [TBL] [Abstract][Full Text] [Related]
40. Characterization and comparison of two newly established Epstein-Barr virus (EBV)-negative and EBV-positive Burkitt's lymphoma cell lines. EBV-negative cell line with a low level of expression of ICAM-1 molecule and EBV-positive cell line with a high level of expression of ICAM-1 molecule. Abe M; Tasaki K; Tominaga K; Fukuhara S; Imai S; Osato T; Wakasa H Cancer; 1992 Feb; 69(3):763-71. PubMed ID: 1309680 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]